Analysts’ Consensus Reaffirms Significant Upside Potential For Cardiol Therapeutics
(MENAFN- News Direct) --News Direct-- Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart …